CCND1 and lung adenocarcinoma: Previously, we have shown that EGFR inhibition in EGFR-mutated lung adenocarcinoma cells could induce a very early and significant change of transcription in a small and representative group of key downstream effectors of oncogenic signaling, including important pathway components such as Cyclin D1, AP-1, dual specificity phosphatases etc [20, 29].